Logo of National Eczema Association mobile menu icon
Icon link to National Eczema's Instagram feed. Icon link to National Eczema's YouTube channel. Icon link to National Eczema's Facebook page. Icon link to National Eczema's Twitter feed. Icon link to National Eczema's inspire.com page. Search Icon to search the site

Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

Research

Atopic dermatitis plus food allergy is a unique subtype of eczema

Researchers examined the skin of children who have atopic dermatitis combined with food allergies and identified characteristics that are unique to the dual condition compared to AD alone.

Read More


The bacterial culprit that drives atopic dermatitis

The relationship between atopic dermatitis and Staphylococcus aureus is longstanding and complex. A Dutch company is investing in a new technology that targets staph to help reduce disease severity.

Read More


Researchers investigate Dupixent side effects

In addition to conjunctivitis, a widely reported side effect of the atopic dermatitis biologic Dupixent (dupilumab), researchers report that eosinophilia and facial eczema could also be side effects.

Read More


Researchers discover relationship between scratching, food allergy

The communication pathway between the skin and the gastrointestinal tract may be complex, but it could hold the key to the relationship between AD and food allergies.

Read More


Nasal and skin microbiomes are linked to AD severity in children

A study conducted in The Netherlands found a strong association between the severity of pediatric AD and the composition of bacteria found in both the nasal passages and on the skin.

Read More


Swiss scientists identify link between skin fungi imbalance, atopic dermatitis

The Swiss scientists theorized that the same immune cells that protect us against the normally harmless Malassezia fungus might also play a fundamental role in triggering atopic dermatitis.

Read More


Two new atopic dermatitis biologics show promising results in phase IIb clinical trials

Galderma’s nemolizumab and Dermira’s lebrikizumab are two new biologics for atopic dermatitis that are working their way toward FDA approval.

Read More


Sleep disturbances, exhaustion common among mothers of eczema children

A NEA-funded study found that mothers of children with moderate to severe atopic dermatitis are more likely to experience sleep loss and caregiver fatigue.

Read More


Colorado researchers urge raising the bar for treating severe eczema

The researchers suggest doctors combine basic skincare techniques with cutting-edge treatments to maximize the well-being of their patients.

Read More


The FDA is rethinking the timing of pediatric clinical trials

Historically, pediatric atopic dermatitis patients have been excluded from the early stages of the drug development process, but this soon may change.

Read More